home / stock / itrm / itrm quote
Last: | $1.19 |
---|---|
Change Percent: | -4.8% |
Open: | $1.23 |
Close: | $1.25 |
High: | $1.25 |
Low: | $1.18 |
Volume: | 165,464 |
Last Trade Date Time: | 07/29/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.19 | $1.23 | $1.25 | $1.25 | $1.18 | 165,464 | 07-29-2024 |
$1.25 | $1.25 | $1.25 | $1.29 | $1.2185 | 297,443 | 07-26-2024 |
$1.25 | $1.24 | $1.25 | $1.26 | $1.21 | 131,763 | 07-25-2024 |
$1.255 | $1.3 | $1.255 | $1.31 | $1.22 | 158,422 | 07-24-2024 |
$1.29 | $1.27 | $1.29 | $1.328 | $1.27 | 126,695 | 07-23-2024 |
$1.25 | $1.22 | $1.25 | $1.34 | $1.22 | 375,261 | 07-22-2024 |
$1.22 | $1.29 | $1.22 | $1.29 | $1.21 | 123,379 | 07-19-2024 |
$1.25 | $1.3 | $1.25 | $1.3 | $1.23 | 163,416 | 07-18-2024 |
$1.29 | $1.34 | $1.29 | $1.39 | $1.28 | 240,567 | 07-17-2024 |
$1.345 | $1.51 | $1.345 | $1.54 | $1.28 | 600,925 | 07-16-2024 |
$1.58 | $1.73 | $1.58 | $1.73 | $1.5197 | 906,909 | 07-15-2024 |
$1.64 | $1.65 | $1.64 | $1.7242 | $1.58 | 442,537 | 07-12-2024 |
$1.605 | $1.47 | $1.605 | $1.61 | $1.47 | 1,015,403 | 07-11-2024 |
$1.47 | $1.4 | $1.47 | $1.51 | $1.36 | 331,683 | 07-10-2024 |
$1.35 | $1.28 | $1.35 | $1.38 | $1.26 | 120,112 | 07-09-2024 |
$1.3 | $1.15 | $1.3 | $1.3199 | $1.15 | 155,034 | 07-08-2024 |
$1.15 | $1.1 | $1.15 | $1.1899 | $1.1 | 99,202 | 07-05-2024 |
$1.12 | $1.1 | $1.12 | $1.13 | $1.0676 | 28,032 | 07-04-2024 |
$1.12 | $1.1 | $1.12 | $1.13 | $1.0676 | 28,032 | 07-03-2024 |
$1.09 | $1.09 | $1.09 | $1.09 | $1.05 | 83,969 | 07-02-2024 |
News, Short Squeeze, Breakout and More Instantly...
Iterum Therapeutics plc Company Name:
ITRM Stock Symbol:
NASDAQ Market:
Iterum Therapeutics plc Website:
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
DUBLIN, Ireland and CHICAGO, June 21, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community...
DUBLIN and CHICAGO, June 05, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hosp...